SCHEMBL4248368

SCHEMBL4248368

Cc1c(O)cccc1-c1cccnc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 9/20 0.50
CYP3A4 P08684 3/20 0.50
ALDH1A1 P00352 2/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2E1 P05181 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2B6 P20813 1/20 0.50
CYP2C19 P33261 1/20 0.50
PARP10 Q53GL7 1/20 0.47
PARP11 Q9NR21 1/20 0.47
PTGS2 P35354 1/20 0.45
CYP11B1 P15538 3/20 0.44
CYP11B2 P19099 2/20 0.44
CYP17A1 P05093 1/20 0.44
CYP19A1 P11511 1/20 0.44
KDM4E B2RXH2 1/20 0.44
LMNA P02545 1/20 0.44
TP53 P04637 1/20 0.44
MAPT P10636 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21742825 0.83 PTGS2 (0.54) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2E1
SCHEMBL18378751 0.83 CYP2A6 (0.56) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2E1
SCHEMBL30546895 0.81 CYP2A6 (0.50) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2E1
SCHEMBL29248879 0.81 CYP2A6 (0.50) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2E1
SCHEMBL1155160 0.80 ALDH1A1 (0.60) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2E1
SCHEMBL30070521 0.80 ALDH1A1 (0.60) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2E1
SCHEMBL1771368 0.80 TP53 (0.50) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2E1
SCHEMBL11068804 0.80 NPC1 (0.50) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2E1
SCHEMBL1130074 0.80 CYP2A6 (0.49) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2E1
SCHEMBL18528875 0.79 CYP2A6 (0.52) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2E1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3325471-A1 COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS Genzyme Corporation (US) 2018-05-30 EP disclosed
WO-2017015267-A1 COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS GENZYME CORPORATION (US) 2017-01-26 WO disclosed
CN-102603581-A PYRROLO[2,3-B] PYRIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS PLEXXIKON INC 2012-07-25 CN disclosed
CN-101243084-B Pyrrolo [2,3-B ] pyridine derivatives as protein kinase inhibitors PLEXXIKON INC 2012-03-07 CN disclosed
CN-102206216-A Pyrrolo[2,3-B] pyridine derivatives as protein kinase inhibitors PLEXXIKON INC 2011-10-05 CN disclosed
EP-2081931-A2 FUSED HETEROCYCLIC DERIVATIVES USEFUL AS INHIBITORS OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR Amgen Inc. (US) 2009-07-29 EP disclosed
CN-101243084-A Pyrrolo [2, 3-B ] pyridine derivatives as protein kinase inhibitors PLEXXIKON INC (US) 2008-08-13 CN disclosed
WO-2008008539-A2 FUSED HETEROCYCLIC DERIVATIVES USEFUL AS INHIBITORS OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR AMGEN INC. (US) 2008-01-17 WO disclosed